Jazz Pharmaceuticals (JAZZ) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 418.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 418.59% |
| Dec 31, 2025 | 6.46% |
| Sep 30, 2025 | 16.77% |
| Jun 30, 2025 | -526.12% |
| Mar 31, 2025 | -591.63% |
| Dec 31, 2024 | 101.96% |
| Sep 30, 2024 | 46.77% |
| Jun 30, 2024 | 58.91% |
| Mar 31, 2024 | -118.89% |
| Dec 31, 2023 | 139.44% |
| Sep 30, 2023 | 956.50% |
| Jun 30, 2023 | 185.74% |
| Mar 31, 2023 | 1,109.01% |
| Dec 31, 2022 | -641.80% |
| Sep 30, 2022 | 65.45% |
| Jun 30, 2022 | 110.18% |
| Mar 31, 2022 | -95.05% |
| Dec 31, 2021 | -124.13% |
| Sep 30, 2021 | -133.31% |
| Jun 30, 2021 | -412.61% |
| Mar 31, 2021 | 174.48% |
| Dec 31, 2020 | 78.03% |
| Sep 30, 2020 | 44.09% |
| Jun 30, 2020 | -55.61% |
| Mar 31, 2020 | -283.49% |
| Dec 31, 2019 | -53.04% |
| Sep 30, 2019 | -31.04% |
| Jun 30, 2019 | 182.83% |
| Mar 31, 2019 | 85.87% |
| Dec 31, 2018 | -31.07% |
| Sep 30, 2018 | 134.80% |
| Jun 30, 2018 | -12.19% |
| Mar 31, 2018 | -46.55% |
| Dec 31, 2017 | 98.84% |
| Sep 30, 2017 | -29.06% |
| Jun 30, 2017 | -7.59% |
| Mar 31, 2017 | 14.32% |
| Dec 31, 2016 | 41.33% |
| Sep 30, 2016 | 2.24% |
| Jun 30, 2016 | 29.95% |
| Mar 31, 2016 | 7.23% |
| Dec 31, 2015 | 1.41% |
| Sep 30, 2015 | 241.35% |
| Jun 30, 2015 | 102.16% |
| Mar 31, 2015 | 175.50% |
| Jun 30, 2012 | -111.95% |
| Mar 31, 2012 | -111.70% |
| Jun 30, 2011 | 221.38% |